Legend Biotech Cash Flow from Operating Activities 2019-2025 | LEGN
Legend Biotech cash flow from operating activities for the twelve months ending March 31, 2025 was $-0.150B, a 77.49% decline year-over-year.
- Legend Biotech annual cash flow from operating activities for 2024 was $-0.144B, a 63.38% decline from 2023.
- Legend Biotech annual cash flow from operating activities for 2023 was $-0.393B, a 95.39% increase from 2022.
- Legend Biotech annual cash flow from operating activities for 2022 was $-0.201B, a 1.42% increase from 2021.